Skip Nav Destination
Insulin signaling in insulin receptor substrate (IRS)-1-deficient brown adipocytes: requirement of IRS-1 for lipid synthesis.
Topics: adipocytes , insulin , insulin receptor substrate proteins , irs1 protein, human , lipogenesis
Diabetes November 1999, Vol.48, 2122-2131. doi:https://doi.org/10.2337/diabetes.48.11.2122
X J Cai; P S Widdowson; J Harrold; S Wilson; R E Buckingham; J R Arch; M Tadayyon; J C Clapham; J Wilding; G Williams
Diabetes November 1999, Vol.48, 2132-2137. doi:https://doi.org/10.2337/diabetes.48.11.2132
Diabetes-prone and diabetes-resistant BB rats share a common major diabetes susceptibility locus, iddm4: additional evidence for a "universal autoimmunity locus" on rat chromosome 4.
Diabetes November 1999, Vol.48, 2138-2144. doi:https://doi.org/10.2337/diabetes.48.11.2138
Lack of association between duration of breast-feeding or introduction of cow's milk and development of islet autoimmunity.
J J Couper; C Steele; S Beresford; T Powell; K McCaul; A Pollard; S Gellert; B Tait; L C Harrison; P G Colman
Diabetes November 1999, Vol.48, 2145-2149. doi:https://doi.org/10.2337/diabetes.48.11.2145
Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.
Diabetes November 1999, Vol.48, 2150-2156. doi:https://doi.org/10.2337/diabetes.48.11.2150
Peptides derived from murine insulin are diabetogenic in both rats and mice, but the disease-inducing epitopes are different: evidence against a common environmental cross-reactivity in the pathogenicity of type 1 diabetes.
Diabetes November 1999, Vol.48, 2157-2165. doi:https://doi.org/10.2337/diabetes.48.11.2157
Heterophile anti-mouse immunoglobulin antibodies may interfere with cytokine measurements in patients with HLA alleles protective for type 1A diabetes.
M J Redondo; P A Gottlieb; T Motheral; C Mulgrew; M Rewers; S Babu; E Stephens; D R Wegmann; G S Eisenbarth
Diabetes November 1999, Vol.48, 2166-2170. doi:https://doi.org/10.2337/diabetes.48.11.2166
Diabetes November 1999, Vol.48, 2171-2181. doi:https://doi.org/10.2337/diabetes.48.11.2171
Disruption of circadian insulin secretion is associated with reduced glucose uptake in first-degree relatives of patients with type 2 diabetes.
Diabetes November 1999, Vol.48, 2182-2188. doi:https://doi.org/10.2337/diabetes.48.11.2182
Inhibitory effects of leptin-related synthetic peptide 116-130 on food intake and body weight gain in female C57BL/6J ob/ob mice may not be mediated by peptide activation of the long isoform of the leptin receptor.
Diabetes November 1999, Vol.48, 2204-2209. doi:https://doi.org/10.2337/diabetes.48.11.2204
Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women.
Diabetes November 1999, Vol.48, 2210-2214. doi:https://doi.org/10.2337/diabetes.48.11.2210
Diabetes induces an impairment in the proteolytic activity against oxidized proteins and a heterogeneous effect in nonenzymatic protein modifications in the cytosol of rat liver and kidney.
Diabetes November 1999, Vol.48, 2215-2220. doi:https://doi.org/10.2337/diabetes.48.11.2215
Modifications induced by LDL from type 1 diabetic patients on endothelial cells obtained from human umbilical vein.
Diabetes November 1999, Vol.48, 2221-2228. doi:https://doi.org/10.2337/diabetes.48.11.2221
Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.
M E Cooper; D Vranes; S Youssef; S A Stacker; A J Cox; B Rizkalla; D J Casley; L A Bach; D J Kelly; R E Gilbert
Topics: diabetes mellitus, experimental , kidney , vascular endothelial growth factor a , vascular endothelial growth factor receptor-2
Diabetes November 1999, Vol.48, 2229-2239. doi:https://doi.org/10.2337/diabetes.48.11.2229
Diabetes November 1999, Vol.48, 2240-2245. doi:https://doi.org/10.2337/diabetes.48.11.2240
Diabetes November 1999, Vol.48, 2246-2251. doi:https://doi.org/10.2337/diabetes.48.11.2246